Coldwater Creek Inc. (NASDAQ:CWTR) seems to be on its way down again. Yesterday, the stock soared approximately 42% on its price, and its volume exceeded 5 million shares. However, today the high trade was broken with no reasonable explanation.

Following the records, we can see that the recent price jump happened after Coldwater announced its improved financial results for the second quarter of this year. According to the report, the company has increased its revenue and gross profit, though it has incurred a net loss of approximately $5 million. This year, Coldwater opened five new premium retail stores, however, its cash decreased and the expenses totaled $169 million.

Though the losses, the company expects to gain future profit and projects earnings per share in the range of $0.01 to $0.04 for the third quarter of this year. Yesterday, Coldwater Creek was to host a conference call on its financial results, however there’s no further news on this issue yet.

Coldwater Creek Inc. is a national specialty retailer of women apparel, accessories, jewelry and gift items sold under the Coldwater Creek brand. Historically, the company used to trade about 50% higher, though since April, this year, the stock entered a downtrend. After the high trade yesterday, it is falling down again, so the only question now is what’s the next move of CWTR? It’s just up to be seen.

Yesterday, Law Offices of Howard G. Smith announced that it was investigating potential claims against the board of directors of Phoenix Technologies Ltd. (NASDAQ:PTEC). The investigation appears to be related to the agreement with the Marlin company, and the proposed cash totals approximately $139 million.

According to the press release, Marlin will acquire all outstanding shares of Phoenix common stock for $3.85 per share and the board of directors of Phoenix has already approved the cash transaction.

Looks like after reporting the news, the investors got interested in PTEC and the stock soared over 25% on its price. Along with the price jump, its traded volume exceeded the unusual 20 million shares. That’s a phenomenal value for Phoenix and it immediately placed it among the largest volume increases on NASDAQ.

But what’s going to happen after the big climb?

The latest financial results of PTEC show that its net income and gross profit are a bit lower as compared to the previous period and the company still has a net loss to cover. The good news for Phoenix is that it has more assets than liabilities on its balance sheet and no long-term debt.

Presently, the company is hopeful about its new agreement with Marlin and relies mainly on its financial resources. However, no one knows what’s to follow after the investigation of the Board is closed.

Yesterday, Icagen, Inc. (NASDAQ:ICGN) hit a huge volume gain. Just for a day, the stock sold over 774 thousand shares on the market and gained 8.22% on its price. That’s quite an unusual value for ICGN, as its average volume is only 125 shares traded.

What’s behind the stock’s high momentum then?

Apparently, that’s the news that ICGN won’t be delisted from NASDAQ at least by November, this year. According to Triangle Business Journal, “Nasdaq has granted the company’s request for more time to regain compliance with the $1.00 per share minimum bid price requirement”. Though, Icagen can not guarantee it will be able to reach the minimum price.

Still, last week, the company released another good news on receiving a $3 million milestone payment from Pfizer. Probably, that has impressed the investors, as currently, the stock still moves up.

Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally-administered small molecule drugs that modulate ion channel targets. Historical data shows that last year the company used to trade at over $1 per share, though after that the price fell down.

The ICGN’s first quarter results for this year point that its revenue and gross profit have increased, though it has suffered a net loss. According to the financial report, the company still has more assets than liabilities on its balance sheet, which should be sufficient to cover its current operations. However, ICGN stated that: “A substantial portion of our revenue for at least the next several years will depend on our achieving development and regulatory milestones in our existing collaborative research and development program and entering into new collaborations.”

Icagen claimed that it would need additional funds to meet its obligations and fund operations beyond the third quarter of 2010, and announced that its second quarter results are to be reported on 10 August.

After moving down to $1, Ampio Pharmaceuticals, Inc. (OTC:AMPE) started to climb up again. Yesterday, its price went up to $1.30 per share, and traded volume jumped up tremendously to exceed 2 thousand shares for the day.

What’s behing the present move? It should be the positive announcements along with the optimistic projections, released by AMPE over the last days. Could be these, that made the investors start buying, though the news is related to the future and the high expectations cannot be confirmed yet.

Ampio Pharmaceuticals develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. According to the historical data, AMPE has traded much higher during the last 6 months, when its price reached $4.05 per share. However, there was a shocking price crash in June, this year. After that the stock has had frequent ups and downs to start moving up again. Still, its too soon an uptrend to be recorded.

The quarterly results of AMPE look disappointing. They point that the company has not generated any revenue so far, and it has suffered higher expenses. AMPE still has some cash on hand, though its operating loss has increased.

In its 2010 quarterly report, Ampio states that its: “Cash equivalents consist primarily of money market investments”, and that the company needs to raise additional capital to complete its business plan.

Based on these facts, traders should carefully observe the future movement of the AMPE stock.

Kiley Group, Inc. (PINK:KGRID) stock price has gone flat after losing 99% of value upon announcement of the President Patrick Thomas leaving . The stock price recently hit $0.0003 and carried a huge volume along. This last breath is likely the unfortunate investors getting rid of the stock that lost nearly all of its value.

Presidents changed but the business model remains the same, even though it proved to be ineffective. Well, at least their balance sheet looks good with the $1.5 million in “investments” that auditors didn’t check.

0.0001 fluctuations still kick in, but the volume should eventually set down and in turn the price would go flat once again. For those considering it can only go up from here - this might not be the end after all. There is still 75% drop to the $0.0001 line and some more reverse splits from there on, just like in the past half a year when the share count went from 250M to 14M. This stock is for gambling addicts only!

Bayside Petroleum Company (BYSD.PK) sank down over 50% last week. After a resistance level at $0.030, the stock price ran down to $0.013 and its volume fell to 500 shares traded. Then, all of a sudden, the company’s traded volume ran up to over 3 million shares on Monday! This jump was phenomenal for the pink sheet company and it had no reasonable explanation.

The company has no recent press releases on its website and hasn’t made any general announcements during the last months. However, the records show that BYSD has paid 200k free trading shares to get promoted, which may explain the sudden volume jump.

The promoters can sell their shares right after the promotion, though in the BYSD case the price was probably artificially inflated. But still, we can find no definite explanation on the downtrend, which occurred. We can only assume the promoter has failed and decided to sell all the shares of BYSD.

Last week Krispy Kreme Doughnuts (NYSE:KKD) reported earnings per share of $.06 for the first quarter of fiscal 2011. The Company ended the quarter with a total of 616 Krispy Kreme stores, an increase of 34 locations since January 31, 2010.

Though the company’s revenue for 2009 was lower than the year before, its sales have increased. Last year KKD’s cash flow from operating activities rose up, while its general and administrative expenses dropped.

After the company announced its double earnings, shares in Krispy Kreme were up 6.2 percent. On Friday the market closed at 3.94, and the traded volume exceeded 1 million shares. Today KKD stock reached 4.02 at market cap of 267.74M.

Krispy Kreme is satisfied with the improvement in its first quarter performance and expects a 2011 operating income from $11 million to $15 million.

The company is working to provide better support for its franchise partners and shareholders and publishes all the news on its projects on the Krispy Kreme’s official website.

Cheniere Energy, Inc. (AMEX:LNG) announced its plans to build the first liquefied natural gas export plant in the United States for 40 years. Cheniere intends to make a market revolution and it has already received initial interest from potential buyers and producers interested in committing supply to the project.

After the news was reported, LNG’s stock flew up 12.69% at 3.02 on the high volume of over 1 million shares. It is more than the company’s average traded volume and it still keeps a high value.

During the last weeks, there was a resistance level at 3.0, while currently LNG trades at 3.34 and the maket cap points 191.26M.

Cheniere Energy, Inc. is developing a platform of three, 100%-owned, onshore liquefied natural gas, or LNG, receiving terminals along the U.S. Gulf Coast. According to the records, company’s revenue for 2009 is higher than the year before, but its net income is 2 times lower. However, the LNG’s quarterly results for 2010 look better.

Although the results were consolidated for financial reporting, Cheniere, Sabine Pass LNG, L.P. and Cheniere Partners operate with independent capital structures. In March 2010, Cheniere Marketing entered into an agreement with JPMorgan LNG Co., providing financial support to source more cargoes of LNG than it could source on a stand-alone basis. The next month, the company sold a 30% interest in Freeport LNG, which improved its liquidity and capital positions.

Currently, LNG continues to be involved in oil and gas exploration and believes they have sufficient cash to accomplish the company’s business plan until its debt begins to mature in August 2011.

Yesterday Chimera Investment Corporation (NYSE:CIM) traded in a range between $3.81 and $3.93 and its shares gained 4.24%. Currently, the company trades above their 200-day moving average and its stock price keeps going up.

CIM’s traded volume reached over 11 million shares, which means the market demand has increased during the last days. Though the present uptrend, the analysts expect the price to pullback, based upon its recent resistance level.

However, the financials of Chimera Investment Corporation reported that the company’s net income for 2009 is $324 million, and it gained over $298 million from sales. CIM’s revenue is 3 times higher compared to 2008, and the company’s growth is 183.6% for one year.

Chimera Investment Corporation is externally managed by Fixed Income Discount Advisory Company (FIDAC), a wholly-owned subsidiary of Annaly Capital Management, Inc. The company has been elected to be taxed as a real estate investment trust (REIT) and is required to pay out at least 90% of its earnings to its shareholders to avoid taxation at the corporate level.

Currently, CIM aims to provide attractive risk-adjusted returns to its investors, primarily through dividends and secondarily through capital appreciation.

The PMI Group, Inc. (NYSE:PMI) announced they re-elected all nine directors of the company at their Annual Meeting of Shareholders last week. PMI Chief Executive Officer L. Stephen Smith also remained Chairman of the Board.

Records show that on 28 April, 2010 a downtrend for PMI occurred and it continued approximately 4 weeks. However, during the last days PMI stock is moving up.

After a support level at 4.0, its price rose +10.84%, and the market cap pointed 373.55M. Traded volume has also reached high values and currently, it exceeds 12 million shares.

Though its present price move, PMI Group is currently below its 50-day moving average of $5.19 and should find additional support. The company’s quarterly report for 2010 contains a consolidated net loss of $157 million and increase in debt, which reduced PMI’s revenues by $40.8 million.

PMI Group is one of the largest US providers of mortgage insurance, which protects lenders in case of borrower default. Recently, they announced the PMI shareholders ratified the appointment of Ernst & Young LLP as independent auditors for the company for 2010, and granted approval of the amendment to the PMI Certificate of Incorporation increasing authorized common shares by 100 million.

Cardionet Inc. (NASDAQ:BEAT) made a price jump on the market. After a resistance level at 7.40, yesterday the market closed at $7.71, and the price change pointed +4.05%. As a result, the market cap became 186.00M, and the traded volume reached over 400 thousand shares.

The company has held an uptrend from December, 2009 till mid-May, 2010, when Cardionet Inc. made a relatively low performance. However, the price is currently moving up.

Though its price move, BEAT reported lower revenue for 2010, compared to the year before. However, the company’s balance sheet showed $45 million in cash and no debt for the 3-month period, ended March 31, 2010.

The official BEAT’s website reported they received an FDA approval of their new MCOT platform and the company’s market position remained strong. They also expect to gain share in the cardio thoracic surgery and neurology markets, which will improve their financial results for 2010.

The last news on Cardionet Inc. so far reported that the company’s chairman will be presenting at the Citi 2010 Global Health Care Conference on May 27, 2010 in New York. More details can be found on Internet.

Electro-Optical Sciences, Inc. (NASDAQ:MELA) shares rose after the announcement for upcoming FDA review panel for their key product. MELA reported the FDA’s General and Plastic Surgery Devices Panel will review its MelaFind device, aimed at detecting melanoma, on Aug. 26, 2010.

During the last year, the company’s stock has ranged between $5.51 and $12.24. After a resistance level at 6.0, yesterday the price moved up over 28% to become $7.57, and the market cap reached 174.12M.

Another result of the announcement the company made, was the high volume of over 3 million traded shares, which is far over MELA’s average volume of 400 thousand shares.

Electro-Optical Sciences, Inc. has made quite successful moves recently. The company announced that its stockholders have approved all the proposals voted on at the Company’s 2010 Annual Stockholder Meeting and they expect higher earnings.

Two days ago, the company reported top-line results of their recent US reader study on clinical information, enrolled in a MelaFind pivotal trial, and they scheduled a conference for all the investors.

If the approval of MelaFind turns to be successful, this will bring MELA high revenues in future. For further information on the company’s projects, traders can check its official website.

Vemics Inc. (VMCI.PK) made a phenomenal price jump recently. The company surged up by 15.38% and closed on the price of $0.06 with total volume of over 2 million shares.

Though its market cap reached 7.04M, the VMCI stock price is currently going down. The company’s revenues for the period ended March 31, 2010 decreased by 96%, compared to the year before and it continues to operate at a loss.

Except the fact that Vemics Inc. changed its name to iMedicor, the last news on VMCI website is that the company is to participate in a $11 million SunCoast RHIO program. It combines the services in the recently announced partnership between iMedicor and MedLink and is expected to generate sales of more than $4 million for the first year.

However, there is no further news on this issue and VMCI is dependent on the capital from stock sales and borrowings, while its debt is increasing. Yesterday the price change pointed -11.71% and currently, it keeps going down.

Last year Vemics Inc. had over 18% stock dilution and now the company needs up to $3 million to satisfy their present operating and capital expenditure requirements, as well as more addition funds to complete their business plan.

LYRIC JEANS INC. (LYJN.PK) announced it had taken all the steps to become a Pink Sheets reporting company. It includes entering into the Pink OTC Markets Issuer Services Agreement and assembling the information as required by the Pink Sheets Guidelines for Providing Information.

During the last 3 months, LYJN was promoted a couple of times. Its stock price reached the high of $0.026 and closed on $0.025 with traded volume of over 2 million shares. This immediately put Lyric Jeans Inc. among the top 3 small stocks with big moves on the market.

Though their recent success, LYJN stock price started moving down. Currently, the price change is -10.87%, and yesterday the market closed at $0.002. However, we can’t conclude it’s going to be a long-term downtrend for some of the most prominent members of the entertainment industry joined the company’s advisory council.

LYJN’s historical background shows that last year the company expanded its premium brand from specialty boutiques to department stores and included men’s, toddler’s and jewelry lines in its product range. Presently Lyric Jeans’ team claim they are working hard to provide their shareholders with information which will be available on the Pink Sheets.

Globalstar, Inc. (NASDAQ:GSAT) announced an annual meeting of its stockholders on May 25, 2010. The meeting is related to an upcoming investment community event and will be published on the company’s website.

Though GSAT’s revenue for 2009 was lower than the one for 2008, the company’s net income got higher. Regarding the operating loss for the period ended March 31, 2010, there was an improvement of over $8 million compared to the year before.

Globalstar, Inc. also reported that thanks to its SPOT Satellite GPS Messenger programs and Simplex data initiatives, in March, 2010 the company had over 37 thousand customers more than it had in March, 2009.

Last week GSAT received a regulatory approval for a new mobile satellite service provider in Korea and the company plans to proceed with expanding the market throughout Korea and the surrounding area. Still, customers should check the company’s website for further information and results after its community event.

BioNeutral Group, Inc. (OTC:BONU) reported the signing of an agreement for acquiring all of the shares of Steri-7.

Steri-7 is a UK manufacturer of proprietary formulations in the disinfectant and cleaning field with sales in Europe and the Middle East. The documentation for the new agreement should be finished by the end of May and close by the end of July, 2010.

Reports show that BioNeutral Group’s net income for 2009 is much higher than the year before, but the company has not generated any material revenues. However, after being promoted its stock price kept moving up.

Apart from the new agreement, BONU established an advisory board for the Euro-Asian markets and appointed a new chairman recently, which is expected to increase the revenues of the company.

Currently, the company’s efforts are focused on developing its products and obtaining regulatory approvals for their sale and distribution in the United States and international markets. If these turn to be successful, it will bring BioNeutral Group Inc. a higher profit.

Delta Petroleum Corp. (NASDAQ:DPTR) announced it extended negotiations with Opon International LLC. Opon may take a a 37.5% non-operated working interest in assets, Delta holds in the Piceance Basin in Colorado for $400 million.

As a result of the news, DPTR stock moved up on the market. Yesterday it plunged by 6.09% and closed at $1.22 at market cap 345.00M. The traded volume of DPTR also rose up and exceeded 5 million shares.

Delta Petroleum is an independent oil gas exploration and production company. It holds 49.8% of contract driller DHS Holding and has oil and gas leasehold properties covering approximately 893 thousand undeveloped acres.

The results from Delta’s quarterly report for 2010 show that oil and gas sales increased 55%, but the company reported a net loss attributable to common stockholders of $12.8 million. However, if the present uptrend continues, it will bring higher profit to DPTR.

Generex Biotechnology Corporation (NASDAQ:GNBT) announced it has received two new patents for its proprietary buccal drug delivery system in Japan and Ukraine. These patents will cover the company’s methods of preparation and administration and open up other marketplaces for GNBT.

After this announcement was made, Generex’s shares rose up 5.47% and the market cap became 106.99M. Yesterday the stock closed at $0.42 with total volume of 4.27 million traded shares.

Though Generex Biotechnology Corp. has lost over 11% during the past month, it is currently trading above its 20-day and below its 50-day moving averages.

The company’s financials show that its revenue and net income for 2009 are higher compared to 2008, and the employee growth points 59.3%.

This year GNBT expects the new patents will bring higher profit to its business. At the company’s official website, Generex publishes the news on its projects, as well as a letter to the shareholders with all the information on GNBT’s products and approvals.

Richard Nottenburg, president and CEO of Sonus Networks, Inc. (NASDAQ:SONS), announced his intention to step down by the end of March 2011. Until then Dr. Nottenburg will remain at his current position and assist the board in its search for a new CEO.

Currently, SONS stock is moving up and its shares made a price change of +7.17%. The market cap pointed 698.52M and the company’s traded volume reached over 4 million shares.

After the recent resistance level at 2.35, now SONS sells at 2.54 but we still can’t conclude it’s going to be a long-term uptrend.

Though the company’s revenue and net income for 2009 are lower than the year before, Sonus Networks expects the gross margin for 2010 to be within its longer term target range of 58% to 62%, and the total operating expenses to reach $146 million.

SONS reported they were satisfied with the significant progress the company has made, their clear market strategy and the launch of NBS-5200, the first product on their next generation ConnexIP™ platform.

The company expects to achieve flat to low single digit percent revenue growth for the year and continues to see the opportunity to grow its product revenues faster than the market.

Jones Soda Co. (NASDAQ:JSDA) made a phenomenal price jump these days. After a resistance level at 1.0, its stock rose up 80.77% and the market cap pointed 49.68M. As a result, JSDA made the biggest % change during the last week.

The reason for the sudden price move is the deal for contribution that Jones Soda Co. and Wal-Mart Stores Inc. has signed recently. The day before the deal was announced, shares in Jones Soda were trading at less than 70 cents per share, and now their price keeps rising up.

Along with the price move, JSDA’s traded volume became huge and if it continues to grow, we can talk about big profit. Currently, the volume is over 13 million, which exceeds its average 3-month value of 840 thousand shares.

Though the company’s revenue and net income for 2009 are lower than the year before, if the Walmart deal turns to be successful, JSDA’s capital will increase. The company’s products will be offered to millions of new customers at 3,800 Walmart stores, which is a great success for its business.

Jones Soda’s website contains all the information on its projects and the company’s financials, and the future results are up to be seen.